These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 32897138)

  • 41. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M
    Hossain A; Rahman ME; Rahman MS; Nasirujjaman K; Matin MN; Faruqe MO; Rabbee MF
    Comput Biol Med; 2023 May; 157():106785. PubMed ID: 36931201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M
    Hicks EG; Kandel SE; Lampe JN
    Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery, synthesis and
    Saravana Mani K; Rajamanikandan S; Prabha B
    J Biomol Struct Dyn; 2023; 41(22):13454-13465. PubMed ID: 36744520
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Ramadhan DSF; Siharis F; Abdurrahman S; Isrul M; Fakih TM
    J Biomol Struct Dyn; 2022; 40(22):11526-11532. PubMed ID: 34338602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of polyphenols from
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational studies on the design of NCI natural products as inhibitors to SARS-CoV-2 main protease.
    Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2023 Jun; 41(9):3741-3751. PubMed ID: 35333147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation.
    Bepari AK; Reza HM
    PeerJ; 2021; 9():e11261. PubMed ID: 33954055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening of potential bio-molecules from
    Mathpal S; Sharma P; Joshi T; Joshi T; Pande V; Chandra S
    J Biomol Struct Dyn; 2022; 40(20):9885-9896. PubMed ID: 34151733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies.
    Gupta S; Singh AK; Kushwaha PP; Prajapati KS; Shuaib M; Senapati S; Kumar S
    J Biomol Struct Dyn; 2021 Aug; 39(12):4334-4345. PubMed ID: 32476576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
    Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
    J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, molecular docking and dynamics studies of pyridazino[4,5-
    Moghimi P; Sabet-Sarvestani H; Shiri A
    J Biomol Struct Dyn; 2023; 41(22):13198-13210. PubMed ID: 36951505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 M
    Elseginy SA
    J Biomol Struct Dyn; 2022; 40(24):13658-13674. PubMed ID: 34676801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2
    Khan SA; Zia K; Ashraf S; Uddin R; Ul-Haq Z
    J Biomol Struct Dyn; 2021 Apr; 39(7):2607-2616. PubMed ID: 32238094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On the search for COVID-19 therapeutics: identification of potential SARS-CoV-2 main protease inhibitors by virtual screening, pharmacophore modeling and molecular dynamics.
    Hassan A; Arafa RK
    J Biomol Struct Dyn; 2022 Oct; 40(17):7815-7828. PubMed ID: 33749545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential of (
    El-Hawary SS; Issa MY; Ebrahim HS; Mohammed AF; Hayallah AM; El-Kadder EMA; Sayed AM; Abdelmohsen UR
    Nat Prod Res; 2022 Jun; 36(11):2843-2847. PubMed ID: 33949276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.
    Muhammad I; Rahman N; Gul-E-Nayab ; Niaz S; Basharat Z; Rastrelli L; Jayanthi S; Efferth T; Khan H
    Comput Biol Med; 2021 Jun; 133():104362. PubMed ID: 33894500
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Erdogan T
    J Biomol Struct Dyn; 2023 Apr; 41(6):2448-2465. PubMed ID: 35088655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation.
    Aouidate A; Ghaleb A; Chtita S; Aarjane M; Ousaa A; Maghat H; Sbai A; Choukrad M; Bouachrine M; Lakhlifi T
    J Biomol Struct Dyn; 2021 Aug; 39(12):4522-4535. PubMed ID: 32552534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-silico drug repurposing for targeting SARS-CoV-2 main protease (M
    Sharma S; Deep S
    J Biomol Struct Dyn; 2022 Apr; 40(7):3003-3010. PubMed ID: 33179568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.